Indivior ( (GB:INDV) ) just unveiled an announcement.
Indivior PLC announced that Robert Schriesheim, a Non-Executive Director, has acquired 58,833 ordinary shares at an average price of $8.5644 per share. This transaction increases Schriesheim’s total shareholding in the company to 80,233 shares, reflecting a significant personal investment and potential confidence in the company’s future performance.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and commercialization of medications for the treatment of addiction and its co-occurring disorders. The company is known for its innovative approaches to addiction treatment, particularly in the realm of opioid dependency.
YTD Price Performance: -36.43%
Average Trading Volume: 302,050
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £810.1M
Learn more about INDV stock on TipRanks’ Stock Analysis page.